IBDEI3A7 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,52372,2)
 ;;=^5015570
 ;;^UTILITY(U,$J,358.3,52373,0)
 ;;=N11.9^^193^2531^4
 ;;^UTILITY(U,$J,358.3,52373,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52373,1,3,0)
 ;;=3^Chronic Tubulo-Interstitial Nephritis,Unspec
 ;;^UTILITY(U,$J,358.3,52373,1,4,0)
 ;;=4^N11.9
 ;;^UTILITY(U,$J,358.3,52373,2)
 ;;=^5015574
 ;;^UTILITY(U,$J,358.3,52374,0)
 ;;=N30.91^^193^2531^5
 ;;^UTILITY(U,$J,358.3,52374,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52374,1,3,0)
 ;;=3^Cystitis,Unspec w/ Hematuria
 ;;^UTILITY(U,$J,358.3,52374,1,4,0)
 ;;=4^N30.91
 ;;^UTILITY(U,$J,358.3,52374,2)
 ;;=^5015643
 ;;^UTILITY(U,$J,358.3,52375,0)
 ;;=N30.90^^193^2531^6
 ;;^UTILITY(U,$J,358.3,52375,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52375,1,3,0)
 ;;=3^Cystitis,Unspec w/o Hematuria
 ;;^UTILITY(U,$J,358.3,52375,1,4,0)
 ;;=4^N30.90
 ;;^UTILITY(U,$J,358.3,52375,2)
 ;;=^5015642
 ;;^UTILITY(U,$J,358.3,52376,0)
 ;;=N28.84^^193^2531^7
 ;;^UTILITY(U,$J,358.3,52376,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52376,1,3,0)
 ;;=3^Pyelitis Cystica
 ;;^UTILITY(U,$J,358.3,52376,1,4,0)
 ;;=4^N28.84
 ;;^UTILITY(U,$J,358.3,52376,2)
 ;;=^5015628
 ;;^UTILITY(U,$J,358.3,52377,0)
 ;;=N28.85^^193^2531^8
 ;;^UTILITY(U,$J,358.3,52377,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52377,1,3,0)
 ;;=3^Pyeloureteritis Cystica
 ;;^UTILITY(U,$J,358.3,52377,1,4,0)
 ;;=4^N28.85
 ;;^UTILITY(U,$J,358.3,52377,2)
 ;;=^270372
 ;;^UTILITY(U,$J,358.3,52378,0)
 ;;=N15.1^^193^2531^9
 ;;^UTILITY(U,$J,358.3,52378,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52378,1,3,0)
 ;;=3^Renal & Perinephric Abscess
 ;;^UTILITY(U,$J,358.3,52378,1,4,0)
 ;;=4^N15.1
 ;;^UTILITY(U,$J,358.3,52378,2)
 ;;=^270371
 ;;^UTILITY(U,$J,358.3,52379,0)
 ;;=N16.^^193^2531^10
 ;;^UTILITY(U,$J,358.3,52379,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52379,1,3,0)
 ;;=3^Tubulo-Interstitial D/O in Diseases Classigied Elsewhere
 ;;^UTILITY(U,$J,358.3,52379,1,4,0)
 ;;=4^N16.
 ;;^UTILITY(U,$J,358.3,52379,2)
 ;;=^5015597
 ;;^UTILITY(U,$J,358.3,52380,0)
 ;;=N15.9^^193^2531^11
 ;;^UTILITY(U,$J,358.3,52380,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52380,1,3,0)
 ;;=3^Tubulo-Interstitial Disease,Unspec
 ;;^UTILITY(U,$J,358.3,52380,1,4,0)
 ;;=4^N15.9
 ;;^UTILITY(U,$J,358.3,52380,2)
 ;;=^5015596
 ;;^UTILITY(U,$J,358.3,52381,0)
 ;;=N12.^^193^2531^12
 ;;^UTILITY(U,$J,358.3,52381,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52381,1,3,0)
 ;;=3^Tubulo-Interstitial Nephritis,Not Spec as Acute or Chronic
 ;;^UTILITY(U,$J,358.3,52381,1,4,0)
 ;;=4^N12.
 ;;^UTILITY(U,$J,358.3,52381,2)
 ;;=^5015575
 ;;^UTILITY(U,$J,358.3,52382,0)
 ;;=N28.86^^193^2531^14
 ;;^UTILITY(U,$J,358.3,52382,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52382,1,3,0)
 ;;=3^Ureteritis Cystica
 ;;^UTILITY(U,$J,358.3,52382,1,4,0)
 ;;=4^N28.86
 ;;^UTILITY(U,$J,358.3,52382,2)
 ;;=^5015629
 ;;^UTILITY(U,$J,358.3,52383,0)
 ;;=A08.0^^193^2532^6
 ;;^UTILITY(U,$J,358.3,52383,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52383,1,3,0)
 ;;=3^Enteritis,Rotaviral
 ;;^UTILITY(U,$J,358.3,52383,1,4,0)
 ;;=4^A08.0
 ;;^UTILITY(U,$J,358.3,52383,2)
 ;;=^5000052
 ;;^UTILITY(U,$J,358.3,52384,0)
 ;;=A08.11^^193^2532^1
 ;;^UTILITY(U,$J,358.3,52384,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52384,1,3,0)
 ;;=3^Acute Gastroenteropathy d/t Norwalk Agent
 ;;^UTILITY(U,$J,358.3,52384,1,4,0)
 ;;=4^A08.11
 ;;^UTILITY(U,$J,358.3,52384,2)
 ;;=^5000053
 ;;^UTILITY(U,$J,358.3,52385,0)
 ;;=A08.19^^193^2532^2
